Posted On: 06/17/2016 12:56:54 PM
Post# of 72447
I can list why B is better in my sleep. The average dosing duration (IV) of Omadacycline is 4.3 days. The insurance companies are going to love that.
"The mean (standard deviation [SD]) duration of study drug exposure in the safety analysis population was 10.0 (3.91) days in omadacycline patients and 9.6 (4.36) days in linezolid patients. In each treatment group, the mean duration of i.v. exposure was 4.3 days."
http://aac.asm.org/content/56/11/5650.full
It took Omadacycline (650 patients) just one year to finish P3. I expect the same for B.
https://clinicaltrials.gov/ct2/show/NCT02378480
"The mean (standard deviation [SD]) duration of study drug exposure in the safety analysis population was 10.0 (3.91) days in omadacycline patients and 9.6 (4.36) days in linezolid patients. In each treatment group, the mean duration of i.v. exposure was 4.3 days."
http://aac.asm.org/content/56/11/5650.full
It took Omadacycline (650 patients) just one year to finish P3. I expect the same for B.
https://clinicaltrials.gov/ct2/show/NCT02378480
Quote:
I note that a certain non-professional on another site is spewing BS about the new antibiotic that Paratek is developing.
(0)
(0)
